1017
Three cycles of chemotherapy had been administered without complications when, at the beginning of the fourth cycle, the patient developed clinical and laboratory abnormalities consistent with the development of the hemolytic-uremic syndrome.
 the patient: Subject; hemolytic-uremic syndrome.: Effect; chemotherapy: Treatment; at the beginning of the fourth cycle: Treatment; chemotherapy: Treatment.Drug; fourth cycle: Treatment.Duration
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 the patient: Subject; hemolytic-uremic syndrome.: Effect; chemotherapy: Treatment; at the beginning of the fourth cycle: Treatment; chemotherapy: Treatment.Drug; fourth cycle: Treatment.Duration